SCHEMBL7780667

SCHEMBL7780667

CCn1cc(-c2ccccc2)c(-c2ccc(S(N)(=O)=O)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.51
CA9 Q16790 9/20 0.51
CA1 P00915 8/20 0.51
CA2 P00918 8/20 0.51
CA12 O43570 8/20 0.50
PTGS1 P23219 3/20 0.46
MT-CO2 P00403 1/20 0.46
LMNA P02545 1/20 0.46
CA3 P07451 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
CHRM1 P11229 1/20 0.46
ADRA2B P18089 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
SLC6A2 P23975 1/20 0.46
PDE4A P27815 1/20 0.46
ADORA1 P30542 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780774 0.90 CA9 (0.50) PTGS2CA9CA1CA2CA12
SCHEMBL7773064 0.88 PTGS2 (0.56) PTGS2CA9CA1CA2CA12
SCHEMBL7779955 0.88 PTGS2 (0.51) PTGS2CA9CA1CA2CA12
SCHEMBL7779941 0.88 PTGS2 (0.64) PTGS2PTGS1PTGIR
SCHEMBL7773212 0.86 MEN1 (0.57) PTGS2CA9CA1CA2CA12
SCHEMBL7780104 0.86 PTGS2 (0.55) PTGS2CA9CA1CA2CA12
SCHEMBL7779615 0.85 PTGIR (0.53) PTGS2CA9CA1CA2CA12
SCHEMBL7780847 0.85 CA1 (0.49) PTGS2CA9CA1CA2CA12
SCHEMBL7773166 0.85 PTGIR (0.56) PTGS2CA9CA1CA2CA12
SCHEMBL10434231 0.84 PTGIR (0.55) PTGS2PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed